In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

All About Unlocking Eve: The Initiative Advancing Women In Healthcare Leadership

In Vivo sat down with Eva McLellan and Kaye Vitug to discuss Unlocking Eve, an initiative to bring more women into positions of healthcare leadership

Executive Summary

In Vivo's Chloe Kent discussed the future of women in healthcare leadership with Roche executives and Unlocking Eve founders Eva McLellan and Kaye Vitug.

Self-described as a "movement for transformational change", Unlocking Eve is an initiative which focuses on elevating women in leadership and decision-making roles throughout the healthcare space. Founded by senior Roche Holding AG executives Eva McLellan and Kaye Vitug, the organization recently hosted its debut panel event at the 2022 World Economic Forum in Davos.

In Vivo reporter Chloe Kent sat down with the founders to discuss why women are so underrepresented healthcare leadership, and what employers and the industry can do to foster proactive change over the coming years.

Time stamps:

0:40 What does Unlocking Eve stand for?

3:42 Female leaders in the pandemic

5:11 Securing a seat at the table for women in healthcare leadership

8:11 What defines good sponsorship?

11:05 Quantitative targets

12:19 New leadership models

15:10 Family, parental leave and re-entering the workplace

20:55 What is Unlocking Eve doing to help facilitate change?

23:40 2030 goals

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

IV146690

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel